Dornase alfa biosimiliar (Generium Pharmaceuticals)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDornase alfa biosimiliar (Generium Pharmaceuticals)
Drug Alias Name阿法链道酶Tigerase
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzymeBiologics > Biosimilar
Mechanisms of ActionDeoxyribonuclease 1 repalcementsDNA inhibitors
TargetsDNA
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)FibrosisCystic Fibrosis
Global Approved IndicationsCystic Fibrosis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryRussian Federation
Original Approved Date2019/03/05
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesGenerium Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesGenerium Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsCystic Fibrosis
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Fibrosis

Other Information

ATC CodeR05CB13
Related LinksWikipediaDrugBankKEGG